Epilepsy is one of the most common serious brain conditions, affecting over 70 million
people worldwide. Its incidence has a bimodal distribution with the highest risk in infants and …

Epilepsy surgery is the most effective way to control seizures in patients with drug-resistant
focal epilepsy, often leading to improvements in cognition, behaviour, and quality of life …

Epilepsy affects 65 million people worldwide and entails a major burden in seizure-related
disability, mortality, comorbidities, stigma, and costs. In the past decade, important advances …

Summary The International League Against Epilepsy has recently published a new
classification of epileptic seizures and epilepsies to reflect the major scientific advances in …

Neurosurgery is an underutilized treatment that can potentially cure drug‐refractory
epilepsy. Careful, multidisciplinary presurgical evaluation is vital for selecting patients and to …

This paper reviews advances in epilepsy in recent years with an emphasis on therapeutics
and underlying mechanisms, including status epilepticus, drug and surgical treatments …

Treatment goals for epilepsy are no seizures, no side effects, as soon as possible, but these
goals are too often unmet. Approximately 1 million people in the United States continue to …

BACKGROUND: Neuromodulation-based treatments have become increasingly important in
epilepsy treatment. Most patients with epilepsy treated with neuromodulation do not achieve …

One-third of persons with epilepsy have seizures despite appropriate medical therapy. Drug
resistant epilepsy (DRE) is associated with neurocognitive and psychological decline, poor …

Objective We reviewed data on the epidemiology of epilepsy in the United States and
estimated the prevalence and incidence of drug-resistant temporal lobe epilepsy (TLE) due …